Volume 26, Issue 3, Pages (May 2007)

Slides:



Advertisements
Similar presentations
Volume 11, Issue 4, Pages (April 2007)
Advertisements

Volume 15, Issue 6, Pages (June 2009)
Volume 41, Issue 6, Pages (March 2011)
Volume 55, Issue 1, Pages (July 2014)
Volume 47, Issue 2, Pages (July 2012)
Volume 134, Issue 2, Pages (July 2008)
Volume 36, Issue 2, Pages (October 2009)
Volume 16, Issue 6, Pages (December 2004)
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 138, Issue 5, Pages e2 (May 2010)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
Volume 22, Issue 4, Pages (May 2006)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Peroxisome Proliferator-Activated Receptor-α Is a Functional Target of p63 in Adult Human Keratinocytes  Silvia Pozzi, Michael Boergesen, Satrajit Sinha,
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome  Heather M. Gibson, Anjali Mishra, Derek.
Volume 22, Issue 2, Pages (February 2014)
SUMO Promotes HDAC-Mediated Transcriptional Repression
Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma  Hui-Ju Wen, Michael.
An Acetylation Switch in p53 Mediates Holo-TFIID Recruitment
Direct Interactions of OCA-B and TFII-I Regulate Immunoglobulin Heavy-Chain Gene Transcription by Facilitating Enhancer-Promoter Communication  Xiaodi.
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Minchul Kim, Taekhoon Kim, Randy L. Johnson, Dae-Sik Lim  Cell Reports 
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
EB3 Regulates Microtubule Dynamics at the Cell Cortex and Is Required for Myoblast Elongation and Fusion  Anne Straube, Andreas Merdes  Current Biology 
Volume 25, Issue 3, Pages (February 2007)
Volume 31, Issue 4, Pages (August 2008)
Volume 38, Issue 3, Pages (May 2010)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 9, Issue 1, Pages (January 2006)
C-Jun Downregulation by HDAC3-Dependent Transcriptional Repression Promotes Osmotic Stress-Induced Cell Apoptosis  Yan Xia, Ji Wang, Ta-Jen Liu, W.K.
Volume 30, Issue 4, Pages (May 2008)
Volume 16, Issue 24, Pages (December 2006)
Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking  Qianben Wang, Jason S.
Margaret Tarrant-Elorza, Cyprian C. Rossetto, Gregory S. Pari 
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Volume 10, Issue 3, Pages (September 2006)
Volume 50, Issue 2, Pages (April 2013)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Volume 20, Issue 4, Pages (November 2005)
Volume 36, Issue 2, Pages (October 2009)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Volume 20, Issue 13, Pages (September 2017)
Volume 52, Issue 5, Pages (December 2013)
Volume 25, Issue 5, Pages (March 2007)
Hung-Chun Chang, Leonard Guarente  Cell 
Volume 20, Issue 6, Pages (December 2005)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Ulf Andersson Ørom, Finn Cilius Nielsen, Anders H. Lund  Molecular Cell 
Sang-Hyun Song, Chunhui Hou, Ann Dean  Molecular Cell 
Volume 17, Issue 4, Pages (April 2010)
Volume 49, Issue 5, Pages (March 2013)
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Volume 20, Issue 13, Pages (September 2017)
Volume 29, Issue 1, Pages (January 2008)
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 4, Issue 4, Pages (October 1999)
Xu-Yun Zhao, Siming Li, Guo-Xiao Wang, Qi Yu, Jiandie D. Lin 
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 16, Issue 5, Pages (May 2009)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 62, Issue 3, Pages (May 2016)
Volume 55, Issue 1, Pages (July 2014)
Volume 2, Issue 4, Pages (October 2012)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 41, Issue 4, Pages (February 2011)
Presentation transcript:

Volume 26, Issue 3, Pages 367-379 (May 2007) Mammalian Maf1 Is a Negative Regulator of Transcription by All Three Nuclear RNA Polymerases  Sandra S. Johnson, Cheng Zhang, Jody Fromm, Ian M. Willis, Deborah L. Johnson  Molecular Cell  Volume 26, Issue 3, Pages 367-379 (May 2007) DOI: 10.1016/j.molcel.2007.03.021 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Increased Maf1 Expression Represses Both RNA Pol I- and RNA Pol III-Dependent Gene Activity (A) Transient expression of Maf1 in U87 cells represses transcription of rRNA gene and tRNA gene promoters. The U87 glioblastoma cell line was transiently cotransfected with promoter-reporter plasmids, pArg-maxigene containing a tRNAArg gene, PrHuCAT containing an rRNA gene promoter, or c-fos-Luc, and empty vector or HA-Maf1 expression vector. Total RNA was isolated, and an RNase protection assay (to determine RNA Pol III promoter activity) or a primer extension assay (to determine RNA Pol I promoter activity) was performed. Representative autoradiographs are shown. Protein lysates were isolated for luciferase assays (to determine RNA Pol II promoter activity). Each graph represents at least three independent determinations (average ± standard error [SE]). (B) Transient expression of Maf1 in LN18 cells represses transcription of rRNA gene and tRNA gene promoters. Experiments were performed as indicated in (A) using a LN18 glioblastoma cell line. (C) Expression of HA-Maf1 in U87 and LN18 cells. Immunoblot analysis was performed using protein lysates derived from the transient transfected cells in (A) and (B) using antibodies against HA or β-actin. Representative immunoblots are shown. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Decreased Maf1 Expression Enhances Both RNA Pol I- and RNA Pol III-Dependent Gene Activity (A) Decreased Maf1 expression in U87 cells increases transcription of rRNA and tRNA genes. U87 cells were transiently cotransfected with promoter-reporter plasmids pArg-maxigene, PrHuCAT (RNA Pol I), or c-fos-Luc and empty vector or Maf1 shRNA expression vector. Total RNA was isolated for RNase protection or primer extension assays,and protein lysates were isolated for luciferase assays. Representative autoradiographs are shown. The data represent at least three independent determinations (average ± SE). (B) Decreased Maf1 expression in LN18 cells increases transcription of rRNA and tRNA genes. Experiments were performed as indicated in (A) using the LN18 cell line. (C) Expression of Maf1 in U87 and LN18 cells stably expressing Maf1 shRNA. Cell lines were stably transfected with empty vector or Maf1 shRNA expression vector. Immunoblot analysis was performed using total protein lysates and Maf1 or β-actin antibody. Representative immunoblots are shown. (D) Reducing Maf1 expression enhances endogenous 45S rRNA, tRNA, and 7SL RNA transcription. Total RNA was isolated from U87 cells stably expressing Maf1 shRNA and S1 nuclease protection assay performed to measure precursor 45S rRNA (left panel). Total RNA isolated from U87 cells infected with lentivirus expressing Maf1 shRNA (+) or mismatch RNA (−) was reverse transcribed, and cDNAs were subjected to quantitative real-time PCR measuring precursor tRNALeu (middle panel) or 7SL RNA (right panel). Both tRNALeu and 7SL RNA values were each normalized to values obtained for GAPDH transcripts. Bars represent the average ± SE of at least two independent determinations. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Decreasing Maf1 Expression Selectively Enhances TBP Protein Levels Total cell protein lysates were isolated from U87 cells stably transfected to express Maf1 shRNA or empty vector. Immunoblot analysis was performed and membranes were probed with the indicated antibodies. Representative blots are shown. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Maf1 Represses TBP Promoter Activity through an Elk-1-Binding Site (A) Alterations in Maf1 expression in U87 cells regulate TBP promoter activity. U87 cells were transiently cotransfected with the p4500/+66 hTBP promoter-luciferase plasmid and empty vector or two different concentrations of Maf1-HA expression vector (left) or Maf1 shRNA expression vector (right). The fold change was calculated based on luciferase activity in cells transfected with empty vector for each promoter construct shown (white bars). Bars represent the mean ± SE of at least three independent determinations. (B) Alterations in Maf1 expression in LN18 cells regulate TBP promoter activity. Experiments were performed as indicated in (A) using LN18 cells. (C) Maf1 repression of the TBP promoter requires an Elk-1-binding site. U87 cells were transiently cotransfected with human TBP promoter constructs and either plasmids expressing Maf1-HA, Maf1 shRNA, Maf1 mismatch shRNA, or empty vector. Bars represent the mean relative luciferase units/mg protein/1000 ± SE of at least three independent determinations. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Maf1 Occupies the TBP Promoter and Decreases Elk-1 Occupancy (A) Alterations in Maf1 expression are reciprocal with Elk-1 occupancy at the TBP promoter. Stable U87 cells expressing Maf1-HA (+) or empty vector (−) (left), or infected with lentivirus expressing Maf1 shRNA (+) or mismatch RNA (−) (right) are shown. ChIP analysis was performed with qPCR using primers designed to amplify sequences between +5 and −119 or between −3315 and −3158 relative to the transcription start site as designated in schematic (top). The results shown are the percent of input where immunoprecipitations were performed using either control IgG, Maf1, or Elk-1 antibodies. Bars represent mean ± SE of at least three independent determinations from two separate chromatin preparations. (B) Altering Maf1 expression does not change Elk-1 expression. U87 cells in (A) were subjected to immunoblot analysis with antibodies indicated. A representative blot is shown. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 Maf1 Differentially Regulates Elk-1-Dependent Promoters (A) Alterations in Maf1 expression change TBP and egr-1 expression, but not c-fos and β-actin expression. Total RNA was isolated from U87 cells expressing Maf1-HA (black bars), vector alone (white bars), or Maf1 shRNA (gray bars), or mismatch shRNA (white bars) was subjected to RT-qPCR. Values for each transcript were normalized to values for GAPDH transcript, and the fold change was calculated relative to the expression in control cells. Bars represent the average ± SE of more than three independent determinations. (B) Maf1 occupies the egr-1 promoter and decreases Elk-1 occupancy. ChIP analysis was performed using U87 cells expressing Maf1-HA (black bars), vector alone (white bars), or Maf1 shRNA (gray bars) or mismatch shRNA (white bars) using qPCR with egr-1 promoter-specific primers. Bars represent mean ± SE of at least three independent determinations from two separate chromatin preparations. (C) Maf1 expression does not alter Elk-1 occupancy on the c-fos promoter. ChIP analysis was performed using qPCR with c-fos promoter-specific primers as in (B). (D) Maf1 expression alters egr-1 but not c-fos or actin protein expression. Cell protein lysates derived from the stable U87 cell lines were subjected to immunoblot analysis with antibodies indicated. A representative blot is shown. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 7 Effects of TBP Overexpression and ChIP Analysis on Pol I and Pol III Genes in Cells with Altered Maf1 Expression (A) Increased expression of TBP suppresses the inhibitory effect of Maf1 on Pol I transcription. U87 cells were transiently cotransfected with promoter-reporter plasmids pArg-maxigene or PrHuCAT and Maf1-HA expression vector and/or TBP expression vector. Total RNA was isolated and an RNase protection or a primer extension assay was performed to measure Pol III or Pol I transcription, respectively. Representative autoradiographs are shown. (B) Maf1 does not bind to the rRNA gene promoter. U87 cells expressing Maf1 shRNA, mismatch shRNA, Maf1-HA, or vector alone were subjected to ChIP analysis using qPCR where immunoprecipitations were performed using either control IgG, Maf1, or Elk-1 antibodies. The results shown are the percent of input where bars represent mean ± SE of at least three independent determinations from three separate chromatin preparations. (C) Maf1 occupancy of a tRNA gene is inversely correlated with the occupancy of TFIIIB and Pol III subunits. ChIP analysis of Maf1, Pol III (Rpc155), TFIIIC90, Brf1, and Bdp1 occupancy at the tRNALeu gene promoter in U87 cells expressing Maf1 shRNA (+) or mismatch shRNA (−). Input and IgG control products are shown. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 8 Altered Maf1 Expression Induces Changes in the Transforming and Morphological Properties of U87 Cells (A) Increased Maf1 expression decreases U87 anchorage-independent growth. U87 cells were stably transfected with vector or expression plasmids containing HA- or Flag-epitope-tagged Maf1 cDNA. Immunoblot analysis of U87 stable cells lines was performed using total protein lysates and Maf1, HA, Flag, or β-actin antibody (left panel). To determine accumulation rates (center panel), cells were plated and then harvested daily to determine viable cell numbers by trypan blue exclusion. Values are the mean ± SEM of at least two independent determinations. The U87-Maf1 stable cell lines were analyzed for growth in soft agar (right panel). Colonies greater than 50 μm in diameter were counted 14 days after plating. Values are the mean ± SEM of four independent determinations per cell line. (B) Decreased expression of Maf1 alters cellular morphology. Rhodamine phalloidin (a and c) and α-tubulin (b and d) staining of U87 cells infected with lentivirus expressing mismatch (mm) RNA (left) or Maf1 shRNA (right). Nuclei were stained with DAPI. Scale bar, 50 μm. (C) Decreased Maf1 expression increases cell surface area but does not alter cell volume. U87 cells infected with lentiviral expression constructs containing Maf1 shRNA or a mismatched control shRNA were costained with rhodamine phalloidin and α-tubulin-FITC to delineate the cell margins. Surface area was analyzed using MetaMorph Imaging Software. At least 65 images in 25 fields were analyzed (left). Forward scatter distribution in FACS histograms was utilized to determine relative volumes of U87 cells infected with lentiviral constructs expressing either Maf1 shRNA or a mismatched control shRNA. The histogram is representative of three independent determinations for each cell line. Molecular Cell 2007 26, 367-379DOI: (10.1016/j.molcel.2007.03.021) Copyright © 2007 Elsevier Inc. Terms and Conditions